5 Oversold Biotech Stocks To Buy Right Now

3. Spruce Biosciences, Inc. (NASDAQ:SPRB)

Number of Hedge Fund Holders: 10

14-day RSI Value: 21.7

Spruce Biosciences, Inc. (NASDAQ:SPRB) had 10 hedge funds long its stock in the fourth quarter, with a total stake value of $26.1 million.

Based in South San Francisco, California, Spruce Biosciences, Inc. (NASDAQ:SPRB) develops novel therapies for rare endocrine disorders.

On March 14, JMP Securities’ analyst Jonathan Wolleben maintained a Market Outperform rating and $3 price target on Spruce Biosciences, Inc. (NASDAQ:SPRB).

Follow Spruce Biosciences Inc.